Company: NMP
Filing Date: 2025-05-06
Form Type: S-1
Source: 0001213900-25-039851
Chunk: 5

Company: NMP Acquisition Corp.
Filing Date: 2025-05-06
Form: S-1
Chunk 5
---
 Anti -Dilution Rights of Founder Shares” and “Risk Factors — Risks Relating to our Sponsor and Management Team — Our sponsor paid an aggregate of $25,000, or approximately $0.0065 per founder share, and, accordingly, you will experience immediate and substantial dilution upon the purchase of our ordinary shares ” for further discussion on our sponsor’s and our affiliates’ securities and compensation. Our sponsor and Maxim Group LLC, which we refer to throughout this prospectus as Maxim or the underwriter, have agreed that they and/or their designees will purchase from us an aggregate of 330,000 private placement units (180,000 private placement units to be purchased by our sponsor and 150,000 private placement units to be purchased by Maxim or its designees) at a price of $10.00 per unit for a total purchase price of $3,300,000 in a private placement that will close simultaneously with the closing of this offering. We refer to these units throughout this prospectus as the “private placement units.” Our sponsor and Maxim have also agreed that if the over -allotmentoption is exercised by the underwriters in full or in part, they and/or their designees will purchase from us up to an additional 30,000 private placement units (7,500 private placement units to be purchased by our sponsor, for a total of 187,500 private placement units, and 22,500 private placement units to be purchased by Maxim or its designees, for a total of 172,500 private placement units) at a price of $10.00 per unit in an amount that is necessary to maintain in the trust account $10.00 per unit sold to the public in this offering. The private placement units are identical to the units sold in this offering, subject to limited exceptions described in this prospectus. The private placement units will be sold in a private placement that will close simultaneously with the closing of this offering, including the over -allotmentoption, as applicable. Our sponsor and Maxim have agreed not to transfer, assign or sell any of the private placement units or underlying securities (with certain exceptions) until the completion of our initial business combination. [__] institutional investors (none of which are affiliated with any member of our management, our sponsor or any other investor), which we refer to as the “non -managingsponsor members” throughout this prospectus, have expressed an interest to indirectly acquire interests, through the purchase of non -managingsponsor membership